Logo

American Heart Association

  16
  0


Final ID:

Gene Therapy Strategies, Advantages, and Pitfalls

  • Helms, Adam  ( UNIVERSITY OF MICHIGAN , Ann Arbor , Michigan , United States )
  • Elliott, Perry  ( University College London , London , United Kingdom )
  • Giacca, Mauro  ( Kings College London , London , United Kingdom )
  • Author Disclosures:
    Adam Helms: DO have relevant financial relationships ; Consultant:Lexeo:Active (exists now) ; Consultant:Cytokinetics:Past (completed) ; Consultant:Preload Therapeutics:Active (exists now) ; Research Funding (PI or named investigator):Tenaya:Active (exists now) | Perry Elliott: DO have relevant financial relationships ; Consultant:Pfizer:Active (exists now) ; Consultant:Amicus:Active (exists now) ; Speaker:Chiesi:Active (exists now) ; Speaker:Amicus:Active (exists now) ; Advisor:Solid:Active (exists now) ; Consultant:Forbion:Active (exists now) ; Consultant:Affinia:Active (exists now) ; Consultant:Astra Zeneca:Past (completed) ; Consultant:BMS:Past (completed) | Mauro Giacca: DO have relevant financial relationships ; Consultant:Heqet Tx:Active (exists now) ; Ownership Interest:Forcefield Tx:Active (exists now) ; Consultant:Forcefield Tx:Active (exists now) ; Ownership Interest:Heqet Tx:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Heart Failure Wars: Gene Therapy Strikes Back: An AHA Journals Session

Monday, 11/10/2025 , 01:30PM - 02:45PM

Cardiovascular Seminar

More abstracts on this topic:
Gene Therapy for Storage Cardiomyopathies

Adler Eric, Koeberl Dwight, Byrne Barry

Gene Therapy for Neuromuscular Disorders

Mcnally Elizabeth, Zaidman Craig, Mammen Pradeep

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available